Word

3DBIOLABS

Status

Dead

Status Code

606

Status Date

Monday, February 20, 2023

Serial Number

88174670

Mark Type

3000

Filing Date

Tuesday, October 30, 2018

Published for Opposition

Tuesday, November 19, 2019

Abandoned Date

Monday, February 20, 2023

Trademark Owner History

3D BIOLABS, LLC - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for medical purposes; biological implants, namely, live tissue intended for subsequent implantation

1 Biological tissue, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for scientific and medical research use; artificial organs incorporating live human cells, namely, live tissue for scientific and medical research and use; Pharmaceutical preparations, namely, live cells in the nature of smooth muscle cells, skeletal muscle cells, myocytes, fibroblasts, chondrocytes, adipocytes, fibromyoblasts, ectodermal cells, hepatocytes, organ cells, liver cells, kidney cells, cardiac cells, pancreatic islet cells, cells present in the intestine, stem cells, osteoblasts, cells forming bone or cartilage, hematopoietic cells, parenchymal cells, stroma cells, totipotent cells (iTC), pluripotent cells (iPSC), and progenitor cells (iMSC) for scientific and medical research use

10 Medical device, namely, surgical devices that facilitate the implantation of artificial organs

42 Medical research and development in the field of tissue and cell fabrication

The mark consists of the stylized number and wording "3DBIOLABS" and design. "3D" appears in a larger font and the wording "BIOLABS" appears in a smaller font. The design consists of three stylized geometric shapes stacked on top of each other at an angle above the letters "LAB".
THREE D BIO LABS
Color is not claimed as a feature of the mark.
"3D BIOLABS"

Trademark Events

Feb 21, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Feb 20, 2023

Abandonment - No Use Statement Filed

Jul 28, 2022

Notice Of Approval Of Extension Request E-Mailed

Jul 27, 2022

Sou Extension 5 Granted

Jul 11, 2022

Sou Extension 5 Filed

Jul 27, 2022

Case Assigned To Intent To Use Paralegal

Jul 11, 2022

Teas Extension Received

Jan 12, 2022

Notice Of Approval Of Extension Request E-Mailed

Jan 10, 2022

Sou Extension 4 Granted

Jan 10, 2022

Sou Extension 4 Filed

Jan 10, 2022

Teas Extension Received

Jul 1, 2021

Notice Of Approval Of Extension Request E-Mailed

Jun 29, 2021

Sou Extension 3 Granted

Jun 29, 2021

Sou Extension 3 Filed

Jun 29, 2021

Teas Extension Received

Jan 14, 2021

Notice Of Approval Of Extension Request E-Mailed

Jan 12, 2021

Sou Extension 2 Granted

Jan 12, 2021

Sou Extension 2 Filed

Jan 12, 2021

Teas Extension Received

Jul 15, 2020

Notice Of Approval Of Extension Request E-Mailed

Jul 13, 2020

Sou Extension 1 Granted

Jul 13, 2020

Sou Extension 1 Filed

Jul 13, 2020

Teas Extension Received

Jan 14, 2020

Noa E-Mailed - Sou Required From Applicant

Nov 19, 2019

Official Gazette Publication Confirmation E-Mailed

Nov 19, 2019

Published For Opposition

Oct 30, 2019

Notification Of Notice Of Publication E-Mailed

Oct 14, 2019

Approved For Pub - Principal Register

Oct 8, 2019

Examiner's Amendment Entered

Oct 8, 2019

Notification Of Examiners Amendment E-Mailed

Oct 8, 2019

Examiners Amendment E-Mailed

Oct 8, 2019

Examiners Amendment -Written

Jul 1, 2019

Combined Examiner's Amendment/Priority Action Entered

Jul 1, 2019

Assigned To Lie

Jun 29, 2019

Notification Of Examiner's Amendment/Priority Action E-Mailed

Jun 29, 2019

Examiner's Amendment/Priority Action E-Mailed

Jun 29, 2019

Examiners Amendment And/Or Priority Action - Completed

Feb 12, 2019

Notification Of Non-Final Action E-Mailed

Feb 12, 2019

Non-Final Action E-Mailed

Feb 12, 2019

Non-Final Action Written

Feb 5, 2019

Assigned To Examiner

Nov 15, 2018

Notice Of Design Search Code E-Mailed

Nov 14, 2018

New Application Office Supplied Data Entered

Nov 2, 2018

New Application Entered